COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,861 Articles (22,568 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 768: Articles 7671-7680  | Next

Higher contact among vaccinated can be a mechanism for negative vaccine effectiveness
Bodner, K., Knight, J., Hamilton, M. A., Mishra, S.
10.1101/2022.04.25.22274266 — Posted: 2022-04-27
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Qasmieh, S., Robertson, M. M., Teasdale, C. A., Kulkarni, S. G., Nash, D.
10.1101/2022.04.23.22274214 — Posted: 2022-04-27
Workplace and lifestyle heterogeneity in subjective wellbeing: Latent Class Analysis of UK Time Use Survey before and during COVID-19
Chen, J., Wan, L.
10.1101/2022.04.27.22273297 — Posted: 2022-04-27
The prevalence of SARS-CoV-2 antibodies within the community of a private tertiary university in the Philippines: a serial cross sectional study
Sumpaico-Tanchanco, L. B. C., Sy, J. C. Y., Dy, A. B. C., Levantino, M., Amit, A. M. L., Wong, J., Angeles, K., Vergara, J. P. C.
10.1101/2022.04.25.22274280 — Posted: 2022-04-27
Long-COVID post-viral chronic fatigue syndrome and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study.
Al-Hakeim, H. K., Al-Rubaye, H., Al-Hadrawi, D., Almulla, A., Maes, M.
10.1101/2022.04.25.22274251 — Posted: 2022-04-27
Determinants of motivated behavior are linked to fatigue and its perturbation by SARS-CoV-2 vaccination
Stolz, D. S., Luebber, F., Lange, T., Borgwardt, S., Ziemann, M., Riemekasten, G., Rupp, J., Müller-Pinzler, L., Paulus, F. M., Krach, S.
10.1101/2022.04.23.22274186 — Posted: 2022-04-27
Clinical evaluation of an automated, rapid mariPOC(R) antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infections
Gunell, M., Rantasarkka, K., Arjonen, R., Sanden, A., Vuorinen, T.
10.1101/2022.04.22.22273686 — Posted: 2022-04-27
Targeting Neutrophils Extracellular Traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Veras, F. P., Gomes, G. F., Silva, B. M., Almeida, C., Silva, C. M., Schneider, A. H., Corneo, E. S., Bonilha, C. S., Batah, S. S., Martins, R. P., Arruda, E., Fabro, A. T., Alves-Filho, J. C. A., Cunha, T. M., Cunha, F. Q.
10.1101/2022.04.27.489676 — Posted: 2022-04-27
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
Smits, P. D., Gratzl, S., Simonov, M., Nachimuthu, S. K., Goodwin, B. M., Wang, M. D., Althouse, B. M., Stucky, N.
10.1101/2022.04.26.22271727 — Posted: 2022-04-27
Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study
Malahe, S. R. K., Hoek, R. A. S., Dalm, V. A. S. H., Broers, A. E. C., den Hoed, C. M., Manintveld, O. C., Baan, C. C., van Deuzen, C. M., Papageorgiou, G., Bax, H. I., van Kampen, J. J., Hellemons, M. E., Kho, M. M. L., de Vries, R. D., Molenkamp, R., Reinders, M. E. J., Rijnders, B. J. A.
10.1101/2022.04.25.22273197 — Posted: 2022-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).